SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001437749-24-013742
Filing Date
2024-04-29
Accepted
2024-04-29 17:03:13
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-29

Document Format Files

Seq Description Document Type Size
1 tgtx_ars.pdf ARS 737681
  Complete submission text file 0001437749-24-013742.txt   1017622
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-32639 | Film No.: 24892369
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)